A novel approach for drug response prediction in cancer cell lines via network representation learning
A novel heterogeneous network-based method for drug response prediction in cancer cell lines
An overview of machine learning methods for monotherapy drug response prediction
Autophagy inhibition enhances colorectal cancer apoptosis induced by dual phosphatidylinositol 3-kinase:mammalian target of rapamycin inhibitor NVP-BEZ235
Clinical drug response prediction by using a Lq penalized network-constrained logistic regression method
DeepSurv personalized treatment recommender system using a Cox proportional hazards deep neural network
Diagnostic classification of cancers using extreme gradient boosting algorithm and multi-omics data
Drug response prediction by globally capturing drug and cell line information in a heterogeneous network
Drug sensitivity prediction for cancer cell lines based on pairwise kernels and miRNA profiles
Drug susceptibility prediction against a panel of drugs using kernelized Bayesian multitask learning
Enabling personalized cancer medicine through analysis of gene-expression patterns
FGF19:FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2
Graph Transformer for drug response prediction
GraphCDR a graph neural network method with contrastive learning for cancer drug response prediction
Identification of PA28Î² as a potential novel biomarker in human esophageal squamous cell carcinoma
Improving prediction of phenotypic drug response on cancer cell lines using deep convolutional network
Inhibition of myeloid cell differentiation in cancer the role of reactive oxygen species
miEAA 2.0 integrating multi-species microRNA enrichment analysis and workflow management systems
p53 25 years after its discovery
MEK inhibitors cobimetinib and trametinib, regressed a gemcitabine-resistant pancreatic-cancer patient-derived orthotopic xenograft (PDOX)
MET Activation Mediates Resistance to Lapatinib Inhibition of HER2-Amplified Gastric Cancer CellsAbrogation of Lapatinib Inhibition through MET Activation
Machine learning prediction of cancer cell sensitivity to drugs based on genomic and chemical properties
Optuna A next-generation hyperparameter optimization framework
PaccMann prediction of anticancer compound sensitivity with multi-modal attention-based neural networks
Personalized medicine individualized care of cancer patients
Predicting drug activity against cancer cells by random forest models based on minimal genomic information and chemical properties
Predicting drug response based on multi-omics fusion and graph convolution
Predicting tumor response to drugs based on gene-expression biomarkers of sensitivity learned from cancer cell
RAF-kinase inhibitor protein (RKIP) downregulation in esophageal cancer and its metastases
RefDNN a reference drug based neural network for more accurate prediction of anticancer drug resistance
SWnet a deep learning model for drug response prediction from cancer genomic signatures and compound chemical
The expression patterns and prognostic value of the proteasome activator subunit gene family in gastric cancer based on integrated analysis
Tissue-guided LASSO for prediction of clinical drug response using preclinical samples
USF1 defect drives p53 degradation during Helicobacter pylori infection and accelerates gastric carcinogenesis
